netFormulary NHS
Nottinghamshire Area Prescribing Committee
Joint Formulary
 Formulary Chapter 9: Nutrition and blood - Full Chapter  Expand sub section  Oral sodium and water
Sodium Chloride (Slow Sodium®)
Amber 2
  • 600mg of sodium chloride (= 240mg sodium =10mmol of sodium)
  • Note: Dose (see BNF) is usually many tablets a day as each tablet only contains 600mg and a normal daily adult intake is around 6,000mg.
  • Link to SPC 
    Sodium Chloride 30% oral (5mmol/mL)
    Restricted Drug Restricted

    Oral solution 30% (5mmol/mL), injection used orally

    • Unlicensed special - named patient use
    Link  SFH outpatients should be sent to SFH pharmacy for supplies of unlicensed medicines. Don’t prescribe on FP10HP.
    Expand sub section  Oral rehydration therapy (ORT)
    Oral Rehydration Salts (Dioralyte®)

    Oral powder

    • OTC Patients should be advised to purchase over the counter

    • May be prescribed if appropriate to in-patients; patients should be advised on discharge that further supply should be purchased
     Non Formulary Items

    Non Formulary

    Rehydration sachets

    • Withdrawn from the market on 5th February 2018.
    • For adult patients with high stoma output unable to tolerate St Mark’s solution. Glucodrate also replaces "double strength" Dioralyte (10sachets diluted in the required volume). 
    • Listed as a borderline substance in the drug tariff, therefore requires ACBS endorsement on an FP10 prescription.
    Sodium chloride liquid (5mmol/5mL) SodiClor®

    View adult BNF View SPC online View childrens BNF
    Non Formulary

    GREY non-formulary

    Recommended strength is 5mmol/mL (30%) as per RCPCH guidance

    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Track Changes
    Display tracking information
    click to search
    Link to adult BNF
    click to search
    Link to children's BNF
    click to search
    Link to SPCs
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHS England

    Traffic Light Status Information

    Status Description


    Grey / Non-Formulary: Medicines, which the Nottinghamshire APC has actively reviewed and does not recommend for use at present due to limited clinical and/or cost effective data.
    Grey / Non-Formulary (undergoing assessment): Work is ongoing and will be reviewed at a future APC meeting.
    Grey / Non-Formulary (no formal assessment): APC has not formally reviewed this medicine or indication because it had never been requested for formulary inclusion. Often used for drugs new to market.


    Medicines which should normally be prescribed by specialists only. eg hospital only.
    For patients already receiving prescriptions in primary care - continue. No new patients to receive prescriptions in primary care.

    Amber 1

    Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised.
    Prior agreement must be obtained by the specialist from the primary care provider before prescribing responsibility is transferred. The shared care protocol must have been agreed by the relevant secondary care trust Drugs and Therapeutics Committee(s) (DTC) and approved by the Nottinghamshire APC.

    Amber 2

    Medicines suitable to be prescribed in primary care / general practice after specialist* recommendation or initiation.
    A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust DTCs and approved by the Nottinghamshire APC.
    *Specialist is defined by the APC as a clinician who has undertaken an appropriate formal qualification or recognised training programme within the described area of practice

    Amber 3

    Primary care/ non specialist may initiate as per APC guideline.
    The supporting prescribing guideline must have been agreed by the relevant secondary care trust D&TC(s) and approved by the Nottinghamshire APC.


    Medicines suitable for routine use within primary care.
    Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies, for example the BNF, BNF for Children, Medicines for Children or Palliative Care Formulary. Primary care prescribers take full responsibility for prescribing.